Individualized Medication Management in Ontario Long-Term Care Clinical Impact on Management of Depression, Pain, and Dementia
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 21 (6) , 823-829.e5
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Improved Antidepressant Remission in Major Depression via a Pharmacokinetic Pathway Polygene Pharmacogenetic ReportClinical Psychopharmacology and Neuroscience, 2015
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake InhibitorsClinical Pharmacology & Therapeutics, 2015
- OPRM1 A118G Gene Variant and Postoperative Opioid RequirementAnesthesiology, 2014
- Emergency Department Visits by Adults for Psychiatric Medication Adverse EventsJAMA Psychiatry, 2014
- A Randomized Trial of Genotype-Guided Dosing of WarfarinNew England Journal of Medicine, 2013
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 UpdateClinical Pharmacology & Therapeutics, 2013
- Nursing Home Medical Staff Organization and 30-Day RehospitalizationsJournal of the American Medical Directors Association, 2012
- Nursing Home Medical Staff Organization: Correlates With Quality IndicatorsJournal of the American Medical Directors Association, 2011
- Cytochrome P-450 Polymorphisms and Response to ClopidogrelNew England Journal of Medicine, 2009
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide StudyNew England Journal of Medicine, 2008